Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
2.270
-0.050 (-2.16%)
Feb 2, 2026, 11:45 AM EST - Market open
Treace Medical Concepts Market Cap
Treace Medical Concepts has a market cap or net worth of $144.64 million as of February 2, 2026. Its market cap has decreased by -72.59% in one year.
Market Cap
144.64M
Enterprise Value
160.78M
1-Year Change
-72.59%
Ranking
Category
Stock Price
$2.27
Market Cap Chart
Since the IPO on April 23, 2021, Treace Medical Concepts's market cap has decreased from $889.74M to $144.64M, a decrease of -83.74%. That is a compound annual growth rate of -31.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 147.83M | -5.31% |
| Dec 31, 2025 | 156.11M | -66.32% |
| Dec 31, 2024 | 463.49M | -41.06% |
| Dec 29, 2023 | 786.37M | -38.37% |
| Dec 30, 2022 | 1.28B | 28.74% |
| Dec 31, 2021 | 991.14M | 11.40% |
| Apr 23, 2021 | 889.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapid Micro Biosystems | 196.35M |
| Nano-X Imaging | 188.94M |
| CVRx, Inc. | 179.54M |
| InfuSystem Holdings | 167.98M |
| Apyx Medical | 164.94M |
| Lucid Diagnostics | 163.84M |
| Inogen | 160.18M |
| LENSAR | 152.05M |